Mechanistically, NIPBL co-occupies neuroblastoma-specific enhancers with MYCN, particularly at regulatory regions enriched for core regulatory circuitry (CRC) transcription factor binding motifs. This evidence concerns the gene MYCN and neuroblastoma.